Altreno (Tretinoin Lotion) For Acne

Altreno, a new form of tretinoin was recently approved for the treatment of acne in patients aged 9 years and older. Altreno contains 0.05% tretinoin, in line with previous cream and gel formulations. The main difference between Altreno and previous forms of tretinoin is that Altreno is a lotion. Altreno may cause less skin irritation… Read More

Mini-Pulse Dexamethasone For Vitiligo

Vitiligo is an autoimmune disease in which the body’s immune system attacks the cells that produce pigment. The disease can remain localized, effecting a limited area, or may sometimes be progressive. Most currently available treatments, such as topical steroids or Excimer laser, address lesions that have already formed, but cannot prevent new areas of vitiligo… Read More

Sebaceous Cyst Removal

Sebaceous cysts, also known as epidermal cysts, are among the most common skin problems, usually presenting as a nodule under the skin, often with a punctum connecting to the surface. On the scalp similar cysts are termed pilar cysts. Sometimes there is an unpleasant odor and a cheese-like material may sometimes be expressed from a… Read More

Qbrexza Approved For Hyperhidrosis

Qbrexza (glycopyrronium) cloth has been approved by the for the treatment of underarm sweating, also known as axillary hyperhidrosis. This medication is classified as an anticholinergic and works by interfering with the neurotransmitter that communicates with sweat glands. It is related to the oral medication glycopyrrolate, which has long been used for hyperhidrosis. One cloth… Read More

Dupilumab for Atopic Dermatitis

Dupilumab (brand name Dupixent) is shaping up to be a game-changer in the treatment of atopic dermatitis, often referred to informally as “eczema”. Dupixent addresses an underlying immune dysregulation that contributes to the development of atopic dermatitis. It blocks IL-4 and IL-13, two important cytokines in the TH2 pathway. In a clinical trial, after 12… Read More

Prurigo Nodularis – A Frustrating Problem

Prurigo nodularis (PN) describes a skin condition with firm itchy nodules, in which the skin changes are thought to be secondary to the repetitive trauma of scratching. The lesions can be skin-colored, brown, or red, sometimes with scale, crust, or erosion and ulceration. Lesions of prurigo nodularis are typically on the extensor aspects of the… Read More

Nicotinamide For Skin Cancer Prevention

For those at high risk of developing nonmelanoma skin cancers (NMSC), namely basal cell carcinoma or squamous cell carcinoma, a simple nutritional supplement may reduce the long-term risk. Nicotinamide, a water-soluble form of vitamin B3, has been shown to reduce the incidence of nonmelanoma skin cancer in certain patients. Several studies have shown that 500… Read More

Treatment of Chronic Urticaria (Hives)

Treatment of Urticaria (Hives) Most people will have a bout of hives in their lives. The causes of hives are many, including medications, infections, and physical inducers such as cold, heat, pressure, and sunlight, but for many cases a specific cause cannot be identified. Urticaria is typically classified as acute (<6 weeks) or chronic (>6… Read More

Tranexamic Acid For Melasma

Recently there has been a lot of excitement about the use of tranexamic acid for the treatment of melasma. Tranexamic acid is currently FDA-approved by prescription for the treatment of heavy menstrual bleeding, but off-label studies suggest that it is effective in the treatment of melasma when used at a low dose of 250 to… Read More

Eskata for Seborrheic Ketatoses

Eskata, a new treatment for seborrheic keratoses (SK) has been approved by the Food & Drug Administration. Eskata is a 40% solution of hydrogen peroxide with a custom applicator. In each treatment, each lesion may be treated up to four times, a minute apart. The treatment may be repeated several weeks later. Eskata joins other… Read More